2ZSV
Crystal structure of H-2Kb in complex with JHMV epitope S598
Summary for 2ZSV
Entry DOI | 10.2210/pdb2zsv/pdb |
Related | 2ZSW |
Descriptor | H-2 class I histocompatibility antigen, K-B alpha chain, Beta-2-microglobulin, 8-mer peptide from spike glycoprotein, ... (6 entities in total) |
Functional Keywords | ig fold, protein-protein interactions, immune system, subdominant epitope, glycoprotein, immune response, membrane, mhc i, transmembrane, immunoglobulin domain, secreted |
Biological source | Mus musculus (mouse) More |
Cellular location | Membrane; Single-pass type I membrane protein: P01901 Secreted: P01887 |
Total number of polymer chains | 6 |
Total formula weight | 90482.60 |
Authors | Theodossis, A.,Dunstone, M.A.,Rossjohn, J. (deposition date: 2008-09-18, release date: 2008-11-04, Last modification date: 2023-11-15) |
Primary citation | Butler, N.S.,Theodossis, A.,Webb, A.I.,Nastovska, R.,Ramarathinam, S.H.,Dunstone, M.A.,Rossjohn, J.,Purcell, A.W.,Perlman, S. Prevention of cytotoxic T cell escape using a heteroclitic subdominant viral T cell determinant. Plos Pathog., 4:-, 2008 Cited by PubMed Abstract: High affinity antigen-specific T cells play a critical role during protective immune responses. Epitope enhancement can elicit more potent T cell responses and can subsequently lead to a stronger memory pool; however, the molecular basis of such enhancement is unclear. We used the consensus peptide-binding motif for the Major Histocompatibility Complex molecule H-2K(b) to design a heteroclitic version of the mouse hepatitis virus-specific subdominant S598 determinant. We demonstrate that a single amino acid substitution at a secondary anchor residue (Q to Y at position 3) increased the stability of the engineered determinant in complex with H-2K(b). The structural basis for this enhanced stability was associated with local alterations in the pMHC conformation as a result of the Q to Y substitution. Recombinant viruses encoding this engineered determinant primed CTL responses that also reacted to the wildtype epitope with significantly higher functional avidity, and protected against selection of virus mutated at a second CTL determinant and consequent disease progression in persistently infected mice. Collectively, our findings provide a basis for the enhanced immunogenicity of an engineered determinant that will serve as a template for guiding the development of heteroclitic T cell determinants with applications in prevention of CTL escape in chronic viral infections as well as in tumor immunity. PubMed: 18949029DOI: 10.1371/journal.ppat.1000186 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.8 Å) |
Structure validation
Download full validation report